In 2026, Emcure Pharmaceuticals conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards.The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.
| Metric (tonnes) | 2026 | 2025 |
|---|---|---|
Total Waste Generated | 6,255.97a | 4,203.32a |
Total Waste Recovered | 3,459.81a | 1,876.97a |
Total Hazardous Waste Generated | 4,489.79a | 2,707.95a |
Non-Hazardous Waste Disposed | N/A | N/A |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
In 2026, Emcure Pharmaceuticals generated a total of 6,256metric tonnes of waste.a
Of this amount, 55.3% of Emcure Pharmaceuticals's total waste generated was recovered through methods such as recycling, reuse, or composting, while 17.46% was disposed of through landfilling, incineration, or combustion.The remaining 27.24% was either treated using unspecified methods or not clearly categorized.a
In 2026, Emcure Pharmaceuticals reported a total waste generation of 6,256 metric tonnes, of which 55.3% was recovered through recycling, reuse, or composting.This moderate level of recovery indicates that Emcure Pharmaceuticals is taking steps toward improving its waste diversion practices, though there is still room to enhance recycling and recovery efforts.a
Since 2026, Emcure Pharmaceuticals's total waste generation has increased by 48.83%, which may reflect expanding operations, weaker material efficiency, or insufficient waste reduction efforts.a
Over the same period, Emcure Pharmaceuticals's waste recovery rate increased by 23.85%.a
In 2026, Emcure Pharmaceuticals generated a total of 6,256 metric tonnes of waste.a
Of this amount, 71.77% of Emcure Pharmaceuticals's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment.28.23% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.a
Since 2026, Emcure Pharmaceuticals's total waste generation has increased by 48.83%, which may reflect expanding operations, weaker material efficiency, or insufficient waste reduction efforts.a
Since 2026, Emcure Pharmaceuticals's hazardous waste generation has increased by 11.4%, indicating a potential rise in the use of harmful materials, process inefficiencies, or limited hazardous waste reduction strategies..a
Overall, Emcure Pharmaceuticals has seen a recent increase in both total waste and hazardous waste, which may indicate growing operational pressures or insufficient controls on harmful materials.a